Page 39 - John More News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate announcements from Emmerson PLC, Director/PDMR Shareholding

FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa

FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa PDUFA date of DUBLIN, Ireland, and Boston MA, June 3, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today announces that the U.S. Food and Drug Administration (“FDA”) has granted Priority Review for Amryt’s New Drug Application (“NDA”) for Oleogel-S10 for the treatment of Epidermolysis Bullosa (“EB”).  Oleogel-S10 is a potent...

© Mhairi Edwards/DCT Media John with some sconezones. It’s not every day that people get to turn their passion into a business. But for John More in Bridge of Earn, his love of scones is proving to be a big hit in the local community. These “sconezones” have been making a name for their creator John More, of Bridge of Earn bakery Johns Scone Mad, who turned his passion for making scones into a thriving business two years ago. Following The Courier’s story on his new creation, John has been relishing in his new-found fame, with the story also hitting the headlines elsewhere.

  OnTheMarket plc, the majority agent-owned company which operates the OnTheMarket.com   property portal, is pleased to announce, further to the announcement of 22 March 2021, that it has now completed the acquisition of Glanty Ltd ("Glanty").   The initial consideration of £1,533,477 (the "Initial Consideration") required to be paid by OnTheMarket under the share purchase agreement is being satisfied by way of the issue of 1,528,832 ordinary shares of 0.2 pence each in the capital of OnTheMarket in aggregate (the "Consideration Shares") and ...